[An antiemetic effect of methylprednisolone plus droperidol against nausea and vomiting caused by administration of high-dose adriamycin to breast carcinoma patients]

Gan To Kagaku Ryoho. 1987 Aug;14(8):2560-3.
[Article in Japanese]

Abstract

An antiemetic combination of methylprednisolone and droperidol was administered to 10 patients with breast cancer showing postoperative recurrence, receiving high-dose adriamycin. Methylprednisolone was given twice intravenously at a dose of 500 mg, before and after administration of adriamycin, and droperidol was given just before administration of adriamycin. The 10 patients received a total of 20 chemotherapy courses. Complete relief of vomiting was achieved in 95% of these 20 courses, and mild nausea occurred in 40%. Side effects were drowsiness, acne and akathisia, which were minimal. It was concluded that an antiemetic combination of methylprednisolone and droperidol was very effective for prevention of high-dose adriamycin-induced nausea and vomiting.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Antiemetics / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Doxorubicin / adverse effects*
  • Droperidol / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Humans
  • Methylprednisolone / administration & dosage*
  • Middle Aged
  • Nausea / chemically induced
  • Nausea / prevention & control*
  • Neoplasm Recurrence, Local
  • Vomiting / chemically induced
  • Vomiting / prevention & control*

Substances

  • Antiemetics
  • Doxorubicin
  • Droperidol
  • Methylprednisolone